Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
Ester Aso(Universitat de Barcelona), Isidró Ferrer(Bellvitge University Hospital)
Cited by 149
Related Papers
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
|Frontiers in Pharmacology|2014|229
Functional Genomics Reveals Dysregulation of Cortical Olfactory Receptors in Parkinson Disease: Novel Putative Chemoreceptors in the Human Brain
|Journal of Neuropathology & Experimental Neurology|2013|131
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
|Journal of Alzheimer s Disease|2012|116
Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology
|Neuropathology and Applied Neurobiology|2017|112
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
|Frontiers in Neurology|2017|54